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SUMMARY
There is a trend in the last decade for an increase in early initiation in renal replacement therapy in 
the United States. In 1996 19% of patients initiated dialysis with an estimated glomerular filtration over 
10 ml/min/1,73m2  percentage that actually has increase to 45%. This review will show the reasons 
and evidence behind the current tendencies. There is no factual evidence to support the claim of the 
beneficial effects in early dialysis starts. Data so far shows increase mortality in early dialysis, unrelated 
to the co-morbidities of patients with advanced chronic kidney disease. Residual renal function could 
also be affected by early initiation of dialysis, hampering survival in the long run. Finally will be showing 
the financial burden to the health system. Randomized clinical trials are needed to answer these 
questions. (MED.UIS. 2009;22(3):222-6).
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introduCtion
Chronic Kidney Disease (CKD) has an increasing 
incidence and prevalence. Especially with a prevalence 
of diabetic patients in the United States that exceeds 40 
% as shown in the renal registry of the United States 
Renal Data System (USRDS). The question of how and 
when to start dialysis should be delayed, particularly 
when the patient is still asymptomatic. Many times 
this is not feasible due to the “catastrophic” start of 
some patients, referring to patients who did not have 
a good follow up with a nephrologist with a suitable 
plan for the creation of a vascular access for dialysis, 
appropriate treatment of anemia, blood pressure 
control and the mismatch in bone mineral metabolism 
due to renal disease and nutrition. Absolute indications 
for the start of Renal Replacement Therapy (RRT) 
are: uremic pericarditis or pleuritis, encephalopathy 
or neuropathy, bleeding, hypervolemia refractory to 
diuretics, acid-base and electrolyte abnormalities 
refractory to conventional therapies, persistence of 
nausea and vomiting and signs of malnutrition with 
weight loss. Regarding indications based in the use of 
formulas of Glomerular Filtration Rate (GFR) in the year 
2006 guidelines from the National Kidney Foundation 
Dialysis Outcomes Qualitive Initiative were issued 
recommending the start of RRT in patient with CKD 
stage five (GFR < 15 mL/min/1,73m2). The initiation of 
dialysis before the above mentioned parameters is going 
to depend on the patient’s clinical status. In Europe in 
the year 2005 the European Best Practice guidelines for 
Peritoneal Dialysis recommended dialysis with values 
of GFR below 6 mL/min/1,73m2, considering an early 
start with values between 8-10 mL/min/1,73m2 of GFR. 
In this review we will show the controversies arising 
in the medical literature regarding the early initiation 
of dialysis in patients with CKD stage five and above, 
emphasizing the economical and clinical impact the 
decision entails. Similarly it is shown if this early start 
is damaging from the clinical and survival stand-point 
of view.
WhEn to start dialysis?
 It is difficult to establish the ideal timing for the 
initiation of dialysis in patients with CKD. Diverse 
research groups have tried to answer this question 
based on cohort studies and case series1. These 
researchers advocate that early initiation of dialysis 
with elevated values of GFR will improve morbidity, 
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mortality, employability and quality of life. However 
the clinical studies mentioned are subject to various 
statistical “confounding factors”, like the delay in 
referral to a specialist, age of the patient and other co-
morbidities. Therefore there is no definite conclusion 
for the ideal time to initiate RRT. A recent cohort study 
recommends randomized clinical studies to answer 
this question, but probably these studies will never 
take place2. Despite lack of evidence, expert panels 
of different countries have issued practice guidelines 
that recommend the start of dialysis at levels of GFR 
above the usual parameters. The adoption of these 
recommendations might bring a financial burden 
to our health systems and dialysis services. Data 
concerning these practices have been documented in 
United States, Australia and New Zealand3. It will be 
necessary, in the near future, to perform randomized 
controlled clinical trials that will evaluate the economic 
cost and the prognosis of patients subject to early 
start of RRT. Making an analysis of the data extracted 
from the USRDS it can be seen that there has been an 
increase in the number of patients who started dialysis 
(both hemodialysis and peritoneal dialysis) with GFR 
above 10 ml/min/1,73m24. (Figure 1). In the  year 1996 
15 % of these patients who started RRT did it with 
GFR between 10-14,9 ml/min/1,73m2, ten years later, 
in 2005, this percentage increased to 30 % and 15% 
started with a GFR above 15 ml/min/1,73m2. Similar 
observations were documented in 2007 especially in 
patients with eighty and ninety years of age5. The above 
observations generate the following questions: what is 
the potential impact of this change in current practice 
regarding mortality and morbidity in dialysis? What 
factors led to this change? What are the implications 
of these observations in the incidental dialysis patient 
and the economic burden attached to them?
thE impaCt of Early start on rEnal rEplaCEmEnt 
thErapy
The decision to start RRT in patients with end stage 
renal disease is based on presenting symptoms and 
baseline residual renal function (RRF) values. Some 
researchers have found that 23 % of the population of 
the US with end stage kidney disease (ESKD) started 
dialysis with a GFR below 5 mL/min/1,73 m2 between 
1995 and 19976. In year 1997 the National Kidney 
Foundation published recommendations based on 
the existing literature at the time. They established 
that the start of dialysis was based on an arithmetic 
median equation of the blood urea and the creatinine 
clearance below 10,5 mL/min/1,73 m2 not including 
asymptomatic patients without protein malnutrition. 
One of the studies that initially supported these 
recommendations was the Canusa study, a multicenter 
prospective cohort of  incident patients on Peritoneal 
Dialysis (PD) performed in North America, designed to 
determine the association of membrane transport type 
with patient and technical survival while controlling 
for demographics, clinical variables, nutritional status, 
and adequacy of dialysis. This observational study 
suggested a clinical benefit regarding the preservation 
of creatinine clearance with values of weekly peritoneal 
dialysis clearance of more than 70 L/1,73 m27. Further 
studies, including the ADEMEX, which was a large 
scale prospective, randomized, controlled, clinical trial 
performed in Mexico evaluating the effects of increased 
PD small-solute clearances on mortality rates among 
patients with ESKD who were being treated with 
continous ambulatory PD, questioned these results8. 
Conclusions that were ratified in the HEMO study, a 
prospective, randomized, multicenter, clinical trial 
designed to examine the effects on clinical outcomes of 
two treatment parameters: urea and middle molecules 
clearance utilizing low and high-flux dialysis9. Both 
studies demonstrated the lack of clinical improvement 
(survival) with more elevated clearances of urea 
and serum creatinine in conventional dialysis. In 
the CANUSA study the improvement in survival 
in peritoneal dialysis patients was attributed to the 
existence of a more residual kidney function. If the 
indications by the National Kidney Foundation are 
followed closely and implemented, the risk of strictly 
using these parameters and initiating patients on 
dialysis in an arbitrary manner is patent. Additional 
publications were unable to show clear benefits 
for early start of dialysis. Some clinical studies 
have recommended premature start but presented 
confounding statistical errors regarding survival 
analysis10.
The observational study by Korevaar, did not 
show advantage regarding survival, in early RRT 
initiation11. Traynor showed an increase in mortality 
in an observational study in Europe12. After adjusting 
all co-variants, early dialysis initiation, with GFR more 
than 10 mL/min/1,73m2, is associated with increased 
mortality13. Other studies, using a multivariant Cox 
model, have corroborated these data yielding risk of 
death with each increase of GFR of 5 mL/min/1,73 m2 
at the beginning the dialysis. The confounding factors 
associated to this risk are the possible relationship 
between low levels of creatinine and muscle mass 
reduction or changes in body mass index in reference 
to the percentage of body fat14. As we all know 
dialysis patients have a marked risk of cardiovascular 
mortality. If we compare the population on dialysis 
between the ages of 64-75 years (data extracted from 
USRDS), the ones that began with a GFR between 
5-9,9 mL/min/1,73m2 presented a mortality rate 
during the first year of 25 % that contrasted with the 
patients that started dialysis with a GFR of more than 
15 mL/min/1,73 m2 with a mortality of 41,5 %. The 
relationship between increase mortality and elevated 
GFR at the initiation of dialysis has statistical value 
that persists after including confounding variables 
such as age, sex, race, and co-morbidities (including 
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diabetes). This analysis was based on 900 000 patients 
from the USRDS between the years 1996-2005. 
Murtagh et al showed in his retrospective studies that 
patients older than 75 years with CKD stage five did 
not yield substantial differences in co-morbidity if they 
were receiving RRT or non-dialytic medical therapy  by 
a nephrologist15. 
What arE thE CausEs bEhind an Early start of 
dialysis?
Various hypothesis have been postulated to explain 
the actual tendency for early initiation of dialysis: 
too much reliance in GFR equations rather than 
initiation of RRT based on clinical findings, lack of 
understanding of the recommendations for the proper 
use of  GFR or creatinine clearance formulas and 
the adequate implementation in the decision to start 
dialysis. Management of the different types of CKD 
complications like hypertension, volume overload, 
and anemia through dialytic techniques instead of 
pursuing non-invasive conservative measures, and 
the start of RRT based on signs of malnutrition (hypo-
albuminemia) as well as monetary reasons among other 
causes. This last hypothesis is difficult to prove since 
the same tendency for early starts have been found in 
countries without financial incentives like the United 
Kingdom. In the United States, after analyzing the 
data of the USRDS between the period of 1995-2006, 
there are similar tendencies for the start of dialysis 
based on equal GFR parameters in both subsidized and 
private dialysis units. It is very difficult to pinpoint the 
reason behind this early starts. The lack of randomized 
clinical trials does not support these tendencies. 
Hopefully the IDEAL study, a three year multicenter, 
prospective, randomized controlled performed in 
Australia and New Zealand that will asses the effect of 
commencement of dialysis at two different GFR levels 
on patients outcomes, will shed light in this matter 
soon16.
is it harmful to start rEnal rEplaCEmEnt thErapy 
EarliEr? 
There is lack of evidence regarding the benefit 
of early start of dialysis. Clearly, it is important to 
preserve RRF in patients on RRT8. The preservation 
RRF allows the use of dialysis with low clearances. 
The CANUSA study showed important associations 
between residual renal function at the beginning of 
dialysis and the nutritional status of the patient17. 
Another consideration is the fact that patients older 
than 75 years old have a tendency of lower decrements 
in RRF and increased mortality when they reach CKD 
stage four18. Therefore the early start of dialysis in these 
patients with preserved residual renal function may be 
deleterious due to the fact that dialysis can deteriorate 
RRF faster due to hemodynamic changes increasing 
mortality as well19. Not to mention the complications 
derived from the inappropriate use of vascular access 
in this population, which can lead to infection among 
others. A Cohort study performed on nursing home 
patients, after initiation of hemodialysis, using data 
obtained from  the USRDS, showed marked decline 
in functional status during the period surrounding the 
initiation and by one year after the start of dialysis. 
Findings suggested that in most nursing home 
residents with ESKD, functional decline continous 
despite initiation of dialysis. However, the study fails 
to explain why the decline in functionality despite the 
treatment of uremia, taking in consideration the high 
prevalence of disability at baseline, coexisting medical 
conditions, hospitalizations, physical risks associated 
with the dialysis technique, and the consideration 
that “kidney disease” may be a reflection of terminal 
multiorgan failure rather than a primary cause of 
functional decline20. It is still unknown the trends 
leading this “fashion” of early start of dialysis. Maybe 
it is based on the interpretation, perhaps incorrect 
of guidelines promulgated by different government 
agencies. Guidelines that are based on retrospective 
and observational studies and lack good randomized 
clinical trials as mentioned before.
thE EffECts of Early dialysis start in thE inCidEnCE 
and finanCial Cost of rEnal rEplaCEmEnt thErapy
The phenomenon of early start of dialysis in 
patient with GFR above 10 ml/min/1,73m2 could 
have influenced the increasing costs of Medicare-
IRC in the United States. Marked increase noted in 
the period between 1996-2005. In 2006, the average/
yearly cost of dialysis treatment in patients older than 
65 years was 71 000 dollars. In 2005, 18 076 more 
patients initiated dialysis than in 1996. Additional 
studies are needed to assess the possibility of the 
arbitrary use of GFR equations by nephrologists in 
order to decide when to start RRT in our patients. 
Obviously when indications to start dialysis are 
present (encephalopathy, uremic pericarditis, diuretic 
resistant congestive heart failure, malnutrition) 
there is no doubt should be implemented. However 
a conservative attitude (no dialysis), especially in 
the elderly population with multiple comorbidities 
and with short life-span, represents a better option. 
Some studies suggested this approach, with a similar 
survival to RRT patients21.  There is an inherent 
concern in the trend of early start of RRT. There is 
also the need to design a randomized clinical study to 
answer the paradigm of early or late initiation of RRT 
and its impact on morbidity, mortality, and quality of 
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life in these patients. 
ConClusion
The effects of the “rising tide” on early initiation 
of dialysis is viewed with concern, as it may not be 
justified on the basis of the risk/benefit relationship. 
Efforts should be undertaken now to study the 
phenomenon further with particular emphasis on the 
stability of estimated GFR (eGFR) in CKD stages 4 and 
5. Specifically, a US study of the impact of early versus 
late start of dialysis (using eGFR as a discriminating 
variable) on morbidity, mortality, and quality of life in 
the pre and post dialysis periods could be undertaken. 
This study would differ from the IDEAL protocol in 
that all subjects would be randomized at the early 
start (relative to RRF) to thrice weekly dialysis or to 
thrice weekly assessments and non-dialytic medical 
interventions to balance the benefits of a thrice weekly 
health assessment in a dialysis program. 
Since 1996 there is an upward trend for early start 
of dialysis. The reasons are not obvious and deserve 
accurate studies as mentioned. The basis for starting 
dialysis early (eGFR over 10 mL/min/1,73 m2) may 
be fundamentally flawed, because recent studies do 
not support a positive relationship between dialysis 
clearance as an additive contributor to a patient’s 
overall renal function and to outcomes on dialysis 
treatment. It is clear that the most actual literature 
does not support early initiation due to the lack of data 
regarding renal and patient survival.  In fact, early start 
causes an accelerated loss of RRF with detriment to 
the survival and we all know the epidemiological link 
that exists between preservation of RRF and survival in 
dialysis patients18. Until further studies are published, 
the community of renal physicians and nurses cannot 
recommend the early start of dialysis except in the cases 
listed above. The principal of “first do no harm” should 
be applied in our population with all its consequences.
rEsumEn
¿Existe evidencia para el inicio de terapias renales sustitutivas a 
niveles de filtrado glomerular elevado?
En los Estados Unidos se está notando un incremento del inicio precoz 
de terapias renales sustitutivas en esta última década. Del 19% de 
pacientes que iniciaron diálisis con filtrado glomerular por encima 
de 10 ml/min/1,73m2 en 1996 se ha pasado a un 45%. La presente 
revisión pretende hacer hincapié en este fenómeno, presentado 
evidencia referente a ello. No se conoce si existe beneficio alguno 
para el comienzo precoz de diálisis. Los datos demuestran un 
incremento de la mortalidad en diálisis precoz que no parece ser 
debido a las morbilidades de los pacientes con insuficiencia renal 
crónica terminal. La función renal residual se puede afectar durante 
la diálisis de inicio comprometiendo la supervivencia del paciente a 
largo plazo. Finalmente, se expone el posible gasto financiero que esta 
tendencia acarrea a nuestro sistema de salud. Son necesarios estudios 
clínicos aleatorizados que den respuestas a estos dilemas. (MÉD.UIS. 
2009;22(3):222-6).
Palabras clave: Hemodiálisis. Insuficiencia renal crónica. Insuficiencia 
renal crónica terminal. Terapia renal sustitutiva.
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